Ann: NYR Advances Xolatryp Phase IIa Trial in Cardioprotection, page-37

  1. 924 Posts.
    lightbulb Created with Sketch. 438
    I wonder why NYR talked for years about TBI and stroke, and now suddenly it's all about cardio protection?!

    If the molecule was specifically designed to cross the BBB, this seems a little bit dangerous now that they only need to reach the heart.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
30.0¢
Change
0.010(3.45%)
Mkt cap ! $63.43M
Open High Low Value Volume
29.0¢ 30.0¢ 28.0¢ $277.0K 957.1K

Buyers (Bids)

No. Vol. Price($)
2 31270 29.5¢
 

Sellers (Offers)

Price($) Vol. No.
30.0¢ 130414 1
View Market Depth
Last trade - 15.54pm 07/08/2025 (20 minute delay) ?
NYR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.